Carregant...
Plasma Contact Factors as Therapeutic Targets
Direct Oral Anticoagulants (DOACs) are small molecule inhibitors of the coagulation proteases thrombin and factor Xa that demonstrate comparable efficacy to warfarin for several common indications, while causing less serious bleeding. However, because their targets are required for the normal host-r...
Guardat en:
| Publicat a: | Blood Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6185818/ https://ncbi.nlm.nih.gov/pubmed/30075986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2018.04.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|